Full Press Release Details
SS Innovations International, Inc. Provides
Business Update; Celebrates Achievement of Significant Milestones
Company's flagship SSi Mantra surgical
robotic system utilized to perform successful complex cardiac, lung, head
SSi Mantra used in first pediatric urology surgery
Robotic surgical system has now completed more
than 200 surgeries; clinically validated in India to perform more than 30 different types of surgical procedures
Fort Lauderdale, FL., May 30, 2023 - News Direct
- SS Innovations International, Inc. (the "Company" or "SS Innovations") (OTC: SSII), a developer of innovative
surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provides a business
Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, and a pioneer in robotic cardiothoracic surgery
said, "SS Innovations has achieved significant milestones in 2023, which has the potential
to be a transformational year for the Company. We are delighted with the progress that has been made as we continue to clinically validate
our flagship surgical robotic system, the SSi Mantra.
Innovations has now completed more than 200 surgeries using the SSi Mantra and the system has been validated in India to perform
more than 30 different types of surgical procedures, including thoracic and cardiac surgeries.
"Importantly, we are motivated each day
by our mission to make robotic surgery, with its reduced risk of pain and infection and shorter recovery times, available to the forgotten
world,' the vast populations throughout the world who currently lack access to this type of precision surgery."
Operational Highlights
SS Innovations completed a merger with AVRA
Medical Robotics, Inc., in April 2023 and began trading its common stock on OTC Markets under the ticker symbol "SSII".
About SS Innovations International, Inc.
SS Innovations International, Inc. (OTC: SSII)
is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible
to a larger part of the global population. SSII's product range includes its proprietary "SSI Mantra" surgical robotic
system, and "SSI Mudra", its wide range of surgical instruments capable of supporting a variety of surgical procedures including
robotic cardiac surgery. SSII's business operations are headquartered in India and SSII has plans to expand the presence of its
technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII's
website at ssinnovations.com or LinkedIn for updates.
Forward-Looking Statements
This press release may
contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation
Reform Act of 1995. The words "anticipate," "assume," "believe," "estimate," "expect,"
"will," "intend," "may," "plan," "project," "should," "could,"
"seek," "designed," "potential," "forecast," "target," "objective,"
"goal," or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements
relate to future events or SS Innovations International's future financial performance and involve known and unknown risks, uncertainties
and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any
future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
For more information: